Haemonetics Seeks New Blood With Surprise CEO Exit
This article was originally published in Clinica
Blood management device maker Haemonetics is looking for a permanent President and CEO to replace Brian Concannon, who has resigned from his role after six years at the helm. He will remain with the company until the end of the month. Ronald Gelbman, who has been a long-standing board member, will step in as interim CEO while the company conducts its executive search.